Supernus Pharmaceuticals Competitors and Similar CompaniesClear all
Supernus Pharmaceuticals's competitors and similar companies include Neuraxpharm, moksha8 Pharmaceuticals and Vanda Pharmaceuticals.
 Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. |  Neuraxpharm Neuraxpharm is a pharmaceutical company focusing on the treatment of central nervous system (CNS) disorders. |  moksha8 Pharmaceuticals Moksha8 is a pharmaceutical company which provides therapeutics for the treatment of central nervous system and mental health disorders. |  Vanda Pharmaceuticals Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. | |
Founding Date | Founding Date 2005 | Founding Date 1985 | Founding Date 2006 | Founding Date 2002 |
Type | Type Public | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Rockville, US HQ | Locations Langenfeld (Rheinland), DE HQ Gießhübl, AT Hradec Králové, CZ Paris, FR Budapest, HU Dublin, IE Ascoli Piceno, IT see more | Locations Berwyn, US HQ Ciudad De México, MX | Locations Washington, US HQ Berlin, DE London, GB |
Employees | Employees 6527% increase | Employees 8302% increase | Employees 3702% decrease | Employees 2845% increase |
Valuation ($) | Valuation ($) 1.9 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 273.4 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $661.8m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $198.8m (FY, 2024) |
Net income | Net income $73.9m (FY, 2024) | Net income N/A | Net income N/A | Net income ($18.9m) (FY, 2024) |
Funding | ||||
Total funding raised | Total funding raised $ 69.5m | Total funding raised N/A | Total funding raised $ 224.1m | Total funding raised $ 54m |
For sources of this data, please see the company profile
View Company Profiles
Neuraxpharm
HQ
Langenfeld (Rheinland), DE
Employees
830↑ 2% increase
Neuraxpharm is a pharmaceutical company focusing on the treatment of central nervous system (CNS) disorders.
View companymoksha8 Pharmaceuticals
HQ
Berwyn, US
Employees
370↓ 2% decrease
Moksha8 is a pharmaceutical company which provides therapeutics for the treatment of central nervous system and mental health disorders.
View companyVanda Pharmaceuticals
HQ
Washington, US
Employees
284↑ 5% increase
Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.
View company